Yesterday, after the close of the European session, Kering (KER.FR), one of the largest representatives of the European fashion market, provided its preliminary comments on Q1 2024 results.
The group estimates that its consolidated revenues in the first quarter of 2024 are expected to decline by around 10% compared to the first quarter of last year. The results primarily reflect a steeper decline in sales at Gucci, particularly in the Asia-Pacific region. Gucci's first-quarter comparable revenues are expected to fall nearly 20% year-on-year.
Kering will publish its first-quarter 2024 revenues. April 23 after market. US ADRs based on the company's shares lost nearly 9% during yesterday's US cash session.
US Open: Hope for De-escalation Bolsters Wall Street Bulls
Apple earnings beat Wall Street estimates 🚨 iPhone sales below expectations
🗽S&P 500 companies with the record net margin since 2009 - FactSet data
Market Wrap: UK100 skyrockets after BoE 🇬🇧 🚀 Euphoric gain as ECB Lagarde speaks 🇪🇺 📈
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
